Documents
Application Sponsors
ANDA 208790 | ACS DOBFAR SPA | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 1GM BASE/VIAL | 0 | ERTAPENEM SODIUM | ERTAPENEM SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-04-16 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2020-08-21 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2022-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2022-08-25 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 7 |
SUPPL | 5 | Null | 7 |
SUPPL | 7 | Null | 7 |
TE Codes
CDER Filings
ACS DOBFAR SPA
cder:Array
(
[0] => Array
(
[ApplNo] => 208790
[companyName] => ACS DOBFAR SPA
[docInserts] => ["",""]
[products] => [{"drugName":"ERTAPENEM SODIUM","activeIngredients":"ERTAPENEM SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/16\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208790Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"08\/21\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/21\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-08-21
)
)